Change in HbA(1c) Across the Baseline HbA(1c) Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents

INTRODUCTION: This exploratory post hoc analysis investigated the relative changes in glycated haemoglobin (HbA(1c)) in patients with type 2 diabetes mellitus (T2DM) treated with dulaglutide versus active comparators across a continuous range of baseline HbA(1c) values using data from three phase II...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentilella, Raffaella, Romera, Irene, Nicolay, Claudia, Buzzetti, Raffaella, Vázquez, Luis Alberto, Sesti, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531505/
https://www.ncbi.nlm.nih.gov/pubmed/31055780
http://dx.doi.org/10.1007/s13300-019-0625-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531505/
https://www.ncbi.nlm.nih.gov/pubmed/31055780
http://dx.doi.org/10.1007/s13300-019-0625-3

Ejemplares similares